about
Tempol, a superoxide dismutase mimetic agent, ameliorates cisplatin-induced nephrotoxicity through alleviation of mitochondrial dysfunction in miceRole of the KATP channel in the protective effect of nicorandil on cyclophosphamide-induced lung and testicular toxicity in ratsNephro-toxic effects of intraperitoneally injected EGCG in diabetic mice: involvement of oxidative stress, inflammation and apoptosis.Modulatory Role of Nurr1 Activation and Thrombin Inhibition in the Neuroprotective Effects of Dabigatran Etexilate in Rotenone-Induced Parkinson's Disease in Rats.Exploring the protective role of apocynin, a specific NADPH oxidase inhibitor, in cisplatin-induced cardiotoxicity in rats.Enhancement of amlodipine cardioprotection by quercetin in ischaemia/reperfusion injury in rats.Combination of carvacrol with simvastatin improves the lipid-lowering efficacy and alleviates simvastatin side effects.Protective effects of magnesium supplementation on metabolic energy derangements in lipopolysaccharide-induced cardiotoxicity in mice.Nicorandil ameliorates mitochondrial dysfunction in doxorubicin-induced heart failure in rats: possible mechanism of cardioprotection.Pinocembrin ex vivo preconditioning improves the therapeutic efficacy of endothelial progenitor cells in monocrotaline-induced pulmonary hypertension in rats.Nicorandil enhances the efficacy of mesenchymal stem cell therapy in isoproterenol-induced heart failure in rats.Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.Role of Rho Kinase Inhibition in the Protective Effect of Fasudil and Simvastatin Against 3-Nitropropionic Acid-Induced Striatal Neurodegeneration and Mitochondrial Dysfunction in Rats.Role of nitric oxide and KATP channel in the protective effect mediated by nicorandil in bile duct ligation-induced liver fibrosis in rats.Corrigendum to "Exploring the protective role of apocynin, a specific NADPH oxidase inhibitor, in cisplatin-induced cardiotoxicity in rats" [Chem. Biol. Interact. 207 (2014) 58-66].Naringenin adds to the protective effect of L-arginine in monocrotaline-induced pulmonary hypertension in rats: favorable modulation of oxidative stress, inflammation and nitric oxide.Paradoxical cardiotoxicity of intraperitoneally-injected epigallocatechin gallate preparation in diabetic mice.Cardioprotective effects of ozone oxidative preconditioning in an in vivo model of ischemia/reperfusion injury in rats.Pharmacological preconditioning with nicorandil and pioglitazone attenuates myocardial ischemia/reperfusion injury in rats.Paradoxical effects of atorvastatin in isoproterenol-induced cardiotoxicity in rats: Role of oxidative stress and inflammation.Role of oxidative stress, inflammation, nitric oxide and transforming growth factor-beta in the protective effect of diosgenin in monocrotaline-induced pulmonary hypertension in ratsMesenchymal stem cells therapy enhances the efficacy of pregabalin and prevents its motor impairment in paclitaxel-induced neuropathy in rats: Role of Notch1 receptor and JAK/STAT signaling pathwayPregabalin and lacosamide ameliorate paclitaxel-induced peripheral neuropathy via inhibition of JAK/STAT signaling pathway and Notch-1 receptorMesenchymal stem cells in chemotherapy-induced peripheral neuropathy: A new challenging approach that requires further investigationsPhosphodiestrase-1 and 4 inhibitors ameliorate liver fibrosis in rats: Modulation of cAMP/CREB/TLR4 inflammatory and fibrogenic pathwaysHypoxia-inducible factor 1 alpha and nuclear-related receptor 1 as targets for neuroprotection by albendazole in a rat rotenone model of Parkinson's diseaseBeneficial effects of benfotiamine, a NADPH oxidase inhibitor, in isoproterenol-induced myocardial infarction in rats
P50
Q34278299-8CDA69F0-ED5A-48E4-8B1E-952CA6F2D7FAQ36099894-3DD56874-6EDF-47D6-A1B5-D980AD8880D1Q37591322-B0D82623-56F2-4F75-96CC-3026E251D387Q38701175-218928B5-557F-4396-8380-21523AADCD50Q42708137-78BE82CE-F800-4C4C-98B6-E89B14C744DDQ43286996-1E67AA70-D4AF-48A4-A713-2D799DE6E06DQ46289882-993F9E15-F3E1-40B1-A0B5-90AD4E096F83Q46448729-D145726D-7922-45C2-94DB-1F64ED943B84Q46513899-18575CD2-3340-460C-83BF-8B66302897A9Q46554653-FB2970C9-F0AF-4B29-9F80-B514A56CEAFAQ46862530-AA1CA92B-A07D-4A93-9B1A-ABA1B852B949Q48005483-664ECD57-2E82-4473-9D11-61E2554E449BQ52152147-252C8605-F5BD-4315-A85D-AC18EE2AF768Q52664332-6341B417-C695-4453-BA35-C18FAFB6BA66Q53830351-66DB658C-BBC8-4459-9933-015FE390971FQ53841904-1642E2EC-09C8-4116-A1F1-2465D9C16D23Q54108759-7FA20E70-485C-4813-BEBF-6C50F27AB9C6Q54492925-62E1BF37-A0F9-46AC-873B-79FE7A564ED1Q54591845-33504B5B-76E4-40BB-A744-9AD5469F7E69Q54978202-52C82041-0681-4E90-957A-9D5DA879046FQ87445968-E3E3AF7F-56EC-4BD1-BEEA-489EC6150E87Q90450590-53EF8BA9-F46B-4768-9EFB-E2EA69F0C2C1Q91004623-26F71CBD-1036-464C-9B02-82921519EEF9Q91065021-18128BBF-CE13-47DD-87F5-1E5CACC9F545Q92281753-8452269A-E3A9-4614-9831-8B508D46FBD2Q92591209-0627E75D-CC3A-4451-8A24-A4E24ED5ADB2Q94563416-664291A4-CA2A-4BF2-800E-A271FA2E1AC7
P50
description
investigador
@es
researcher
@en
name
Lamiaa A Ahmed
@en
type
label
Lamiaa A Ahmed
@en
prefLabel
Lamiaa A Ahmed
@en
P31
P496
0000-0003-3476-2815